Market Overview

Benzinga's Top Upgrades, Downgrades For May 21, 2019

Share:

Top Upgrades

  • BMO Capital upgraded Polaris Industries Inc. (NYSE: PII) from Market Perform to Outperform. Polaris shares rose 4.6 percent to $89.89 in pre-market trading.
  • Analysts at Bernstein upgraded Kroger Co (NYSE: KR) from Market Perform to Outperform. Kroger rose 1.5 percent to $24.42 in pre-market trading.
  • Analysts at Canaccord Genuity upgraded Just Energy Group Inc (NYSE: JE) from Hold to Speculative Buy. Just Energy shares rose 1.3 percent to $3.25 in pre-market trading.
  • Guggenheim upgraded Tripadvisor Inc (NASDAQ: TRIP) from Sell to Neutral. TripAdvisor shares rose 1.9 percent to $45.80 in pre-market trading.
  • Bank of America upgraded Deckers Outdoor Corp (NYSE: DECK) from Neutral to Buy. Deckers Outdoor shares rose 0.1 percent to close at $142.74 on Monday.
  • Zelman upgraded Stanley Black & Decker, Inc. (NYSE: SWK) from Hold to Buy. Stanley Black & Decker rose 0.2 percent to close at $135.12 on Monday.
  • Credit Suisse upgraded Apollo Global Management LLC (NYSE: APO) from Neutral to Outperform. Apollo Global shares fell 0.6 percent to close at $32.13 on Monday.
  • Analysts at UBS upgraded S&P Global Inc (NYSE: SPGI) from Neutral to Buy. S&P Global shares fell 0.5 percent to close at $211.83 on Monday.
  • Raymond James upgraded Amneal Pharmaceuticals Inc (NYSE: AMRX) from Market Perform to Strong Buy. Amneal Pharmaceuticals rose 5.1 percent to $8.68 in pre-market trading.

 

Top Downgrades

  • Desjardins downgraded Cae Inc (NYSE: CAE) from Buy to Hold. CAE shares fell 0.4 percent to $26.57 in pre-market trading.
  • RBC Capital downgraded Gran Tierra Energy Inc (NYSE: GTE) from Top Pick to Outperform. Gran Tierra Energy shares closed at $2.14 on Monday.
  • Raymond James downgraded Ocular Therapeutix Inc (NASDAQ: OCUL) from Strong Buy to Outperform. Ocular Therapeutix shares fell 15.7 percent to $2.84 in pre-market trading.
  • Credit Suisse downgraded The Carlyle Group LP (NASDAQ: CG) from Outperform to Neutral. Carlyle shares fell 0.8 percent to close at $20.76 on Monday.
  • Credit Suisse downgraded KKR & Co Inc (NYSE: KKR) from Outperform to Neutral. KKR shares fell 0.7 percent to close at $24.50 on Monday.
  • UBS downgraded Tremont Mortgage Trust (NASDAQ: TRMT) from Buy to Neutral. Tremont Mortgage Trust rose 0.4 percent to close at $5.17 on Monday.

 

Top Initiations

  • Analysts at Credit Suisse initiated coverage on Amgen, Inc. (NASDAQ: AMGN) with an Outperform rating. The price target for Amgen is set to $208. Amgen shares closed at $168.39 on Monday.
  • Consumer Edge Research initiated coverage on Uber Technologies Inc (NYSE: UBER) with an Equal-Weight rating. Uber shares closed at $41.59 on Monday.
  • Deutsche Bank initiated coverage on Target Hospitality Corp (NASDAQ: TH) with a Buy rating. The price target for Target Hospitality is set to $14. Target Hospitality shares closed at $10.83 on Monday.
  • Analysts at Credit Suisse initiated coverage on Incyte Corporation (NASDAQ: INCY) with a Neutral rating. The price target for Incyte is set to $75. Incyte shares closed at $76.83 on Monday.
  • Canaccord Genuity initiated coverage on X4 Pharmaceuticals Inc (NASDAQ: XFOR) with a Buy rating. The price target for X4 Pharmaceuticals is set to $27. X4 Pharmaceuticals closed at $16.96 on Monday.
  • H.C. Wainwright initiated coverage on Aeglea Bio Therapeutics Inc (NASDAQ: AGRX) with a Buy rating. The price target for Aeglea Bio Therapeutics is set to $20. Aeglea Bio Therapeutics shares closed at $6.50 on Monday.
  • Analysts at DA Davidson initiated coverage on Hillenbrand, Inc. (NYSE: HI) with a Neutral rating. The price target for Hillenbrand is set to $43. Hillenbrand closed at $38.96 on Monday.
  • Empire Asset Management initiated coverage on Evolus Inc (NASDAQ: EOLS) with a Sell rating. The price target for Evolus is set to $6. Evolus closed at $17.38 on Monday.
  • Credit Suisse initiated coverage on Biogen Inc (NASDAQ: BIIB) with an Underperform rating. The price target for Biogen is set to $198. Biogen shares closed at $230.76 on Monday.
  • Analysts at Credit Suisse initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) with an Outperform rating. The price target for Vertex Pharmaceuticals is set to $209. Vertex Pharmaceuticals shares closed at $165.73 on Monday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (AMGN + AGRX)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Report: US Officials 'Increasingly' Believe Boeing Ethiopian Crash Was Consequence Of Birds

A Surprise Among Asia-Pacific ETFs